Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

A Study to Test the Safety of the Investigational Drug Larotrectinib in Adults That May Treat Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02122913
Recruitment Status : Completed
First Posted : April 25, 2014
Last Update Posted : May 12, 2021
Sponsor:
Information provided by (Responsible Party):
Bayer

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Completed
Actual Primary Completion Date : February 1, 2017
Actual Study Completion Date : April 9, 2021
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):